Cardiopulmonary Resuscitation - Theoretical Knowledge and Self-perceived Skills Among Swedish Healthcare Professionals

Cardiopulmonary Resuscitation - Theoretical Knowledge and Self-perceived Skills Among Swedish Healthcare Professionals



Sponsors


Source

Dalarna County Council, Sweden

Oversight Info

Has Dmc

No

Is Fda Regulated Drug

No

Is Fda Regulated Device

No


Brief Summary

Theoretical knowledge of cardiopulmonary resuscitation (CPR) is the foundation of being able
to perform CPR in a cardiac arrest situation. The knowledge and skills received in training
is easily lost and after one year the level is equal to pretraining. International studies
regarding knowledge of CPR among healthcare professionals, mostly nurses, show poor results.
The knowledge of CPR among Swedish healthcare professionals is poorly studied.

The aim of this study was to describe the knowledge of CPR and self-perceived skills of
performing CPR among healthcare professionals working in four hospitals in Sweden.

Detailed Description

A questionnaire will be handed out containing a knowledge test of nine questions at a basic
level. The questionnaire also contains Likert-scales that measures four perveived CPR-skills
of the respondents (the ability to take leadership, give compressions, to ventilate and to
defibrillate).

Overall Status

Active, not recruiting

Start Date

2013-12-01

Completion Date

2018-04-30

Primary Completion Date

2017-01-15

Study Type

Observational

Primary Outcome

Measure

Time Frame

Knowledge and the correlation of independent variables.
April 30, 2018
Percevied skills and the correlation of independent variables.
April 30, 2018

Number Of Groups

2

Enrollment

3044

Condition


Eligibility

Study Pop

Healthcare professionals of all professions working in-hospital with patient contact.

Sampling Method

Non-Probability Sample

Criteria

Inclusion Criteria:

- Healtchare professionals of all professions

- Working in-hospital with patient contact

- Present at the time of the survey

Exclusion Criteria:

- Not working with patients

- Abscent at the time of the survey

Gender

All

Minimum Age

18 Years

Maximum Age

N/A

Healthy Volunteers

No


Overall Official

Last Name

Role

Affiliation

Anneli Strömsöe
Study Director
Dalarna County Council

Location

Facility

Avesta Lasarett
Avesta Dalarna 77482 Sweden
Falu Lasarett
Falun Dalarna 79182 Sweden
Mora Lasarett
Mora Dalarna 79129 Sweden
Västmanlands sjukhus
Västerås Västmanland 72189 Sweden

Location Countries

Country

Sweden


Verification Date

2018-04-01

Lastchanged Date

2018-04-12

Firstreceived Date

2018-03-28

Responsible Party

Responsible Party Type

Principal Investigator

Investigator Affiliation

Dalarna County Council, Sweden

Investigator Full Name

Jennie Silverplats

Investigator Title

R.N. PhD candidate


Keywords


Has Expanded Access

No

Condition Browse


Arm Group

Arm Group Label

Healthcare professionals in Dalarna County Council

Description

Healthcare professionals working in-hospital at the hospitals in Mora, Avesta and Falun, Sweden, n=1473.


Arm Group Label

Healthcare professionals in Region Västmanland

Description

Healthcare professionals working in-hospital at the hospital in Västerås, Region Västmanland, Sweden, n=1571.



Firstreceived Results Date

N/A

Firstreceived Results Disposition Date

N/A

Study Design Info

Observational Model

Case-Only

Time Perspective

Cross-Sectional


Study First Submitted

March 28, 2018

Study First Submitted Qc

April 12, 2018

Study First Posted

April 13, 2018

Last Update Submitted

April 12, 2018

Last Update Submitted Qc

April 12, 2018

Last Update Posted

April 13, 2018


ClinicalTrials.gov processed this data on April 13, 2018

Conditions

Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov, conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Interventions

Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied. Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Study Phase

Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions that study is seeking to answer:

In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.

In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.

In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.

In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.

These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.



© 2018 ICH GCP